Rani Therapeutics Holdings (RANI) Non-Current Assets (2020 - 2026)

Rani Therapeutics Holdings has reported Non-Current Assets for 7 years, with the latest figure at $4.3 million in Q2 2026.

• On a quarterly basis, Non-Current Assets fell 25.84% year-over-year to $4.3 million in Q2 2026; TTM through Jun 2026 was $19.6 million, a 35.18% decrease from a year earlier, with the FY2025 full-year figure at $5.3 million, down 23.08% from the prior year.
• Non-Current Assets was $4.3 million for Q2 2026 at Rani Therapeutics Holdings, down from $4.8 million in the prior quarter.
• The five-year high for Non-Current Assets was $12.1 million in Q1 2024, with the low at $4.3 million in Q2 2026.
• Average Non-Current Assets over 5 years is $7.2 million, with a median of $7.0 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets surged 63.91% in 2024, then sank 53.59% in 2025.
• Over 5 years, Non-Current Assets stood at $7.1 million in 2022, then retreated by 0.48% to $7.1 million in 2023, then slipped by 2.53% to $6.9 million in 2024, then slipped by 23.08% to $5.3 million in 2025, then decreased by 18.49% to $4.3 million in 2026.
• The last three Non-Current Assets figures came in at $4.3 million (Q2 2026), $4.8 million (Q1 2026), and $5.3 million (Q4 2025), per Business Quant data.